Amicus Therapeutics Inc (FOLD)
10.71
-0.11
(-1.02%)
USD |
NASDAQ |
Apr 23, 16:00
10.70
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Free Cash Flow (Quarterly): 1.727M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.727M |
| September 30, 2023 | -39.91M |
| June 30, 2023 | -18.34M |
| March 31, 2023 | -20.01M |
| December 31, 2022 | -83.45M |
| September 30, 2022 | -11.49M |
| June 30, 2022 | -16.22M |
| March 31, 2022 | -59.19M |
| December 31, 2021 | -72.27M |
| September 30, 2021 | -24.59M |
| June 30, 2021 | -36.29M |
| March 31, 2021 | -73.22M |
| December 31, 2020 | -50.89M |
| September 30, 2020 | -42.29M |
| June 30, 2020 | -34.59M |
| March 31, 2020 | -108.75M |
| December 31, 2019 | -68.76M |
| September 30, 2019 | -59.53M |
| June 30, 2019 | -60.65M |
| March 31, 2019 | -81.49M |
| December 31, 2018 | -62.41M |
| September 30, 2018 | -135.45M |
| June 30, 2018 | -58.06M |
| March 31, 2018 | -50.34M |
| December 31, 2017 | -74.16M |
| Date | Value |
|---|---|
| September 30, 2017 | -50.02M |
| June 30, 2017 | -43.46M |
| March 31, 2017 | -50.58M |
| December 31, 2016 | -32.03M |
| September 30, 2016 | -41.79M |
| June 30, 2016 | -34.46M |
| March 31, 2016 | -47.81M |
| December 31, 2015 | -38.08M |
| September 30, 2015 | -21.83M |
| June 30, 2015 | -23.31M |
| March 31, 2015 | -21.73M |
| December 31, 2014 | -14.55M |
| September 30, 2014 | -15.18M |
| June 30, 2014 | -11.91M |
| March 31, 2014 | -10.26M |
| December 31, 2013 | -8.17M |
| September 30, 2013 | -13.58M |
| June 30, 2013 | -10.46M |
| March 31, 2013 | -14.27M |
| December 31, 2012 | -7.531M |
| September 30, 2012 | -7.428M |
| June 30, 2012 | -11.99M |
| March 31, 2012 | -11.12M |
| December 31, 2011 | -13.54M |
| September 30, 2011 | -13.20M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-108.75M
Minimum
Mar 2020
1.727M
Maximum
Dec 2023
-46.25M
Average
-42.29M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| TG Therapeutics Inc | -13.21M |
| Geron Corp | -41.00M |
| Vanda Pharmaceuticals Inc | -3.985M |
| Fate Therapeutics Inc | -36.82M |
| Editas Medicine Inc | -23.55M |